Advertisement

Liver Cancer pp 136-149 | Cite as

Hepatic Resection for Colorectal Cancer Metastases

  • Charles R. Shumate
Part of the M.D. Anderson Solid Tumor Oncology Series book series (MDA)

Abstract

Achievement of long-term disease-free survival with surgical resection of metastases requires a single, predictable site of dissemination of the primary cancer. This situation occurs in a small but significant proportion of patients with recurrent colorectal carcinoma. In an ideal setting, treatment for primary or metastatic malignancy provides a high probability for complete response and a reasonable opportunity for long-term disease-free survival, it also has minimal side effects. Numerous methods have been advocated for the treatment of colorectal cancer liver metastases, but unfortunately none satisfies all of these criteria for an ideal treatment. Systemic chemotherapy, regional chemotherapy, cryotherapy, and surgical resection have advocates, but when multiple treatment methods are endorsed for the same problem it suggests that no one method is appropriate for all patients or that substantial treatment response is lacking.

Keywords

Liver Metastasis Liver Resection Inferior Vena Cava Hepatic Vein Hepatic Resection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Registry of Hepatic Metastases. Resection of the liver for colorectal carcinoma metastases: a multi-institution study of indications for resection. Surgery 103:278, 1988Google Scholar
  2. 2.
    Tsao J, Loftus J, Nagorney D, et al. Trends in morbidity and mortality of hepatic resection for malignancy. Ann Surg 220:199, 1994PubMedCrossRefGoogle Scholar
  3. 3.
    Wagner J, Adson M, Van Heerden J, Adson M, Ilstrup D. The natural history of hepatic metastases from colorectal cancer: a comparison with resective treatment. Ann Surg 199:502, 1984PubMedCrossRefGoogle Scholar
  4. 4.
    Cady B, Stone M, McDermott W, et al. Technical and biologic factors in disease-free survival after resection for colorectal cancer metastases. Arch Surg 127:561, 1992PubMedCrossRefGoogle Scholar
  5. 5.
    Steele G, Ravikumar T. Resection of hepatic metastases from colorectal cancer: biologic perspectives. Ann Surg 210:127, 1989PubMedCrossRefGoogle Scholar
  6. 6.
    Furhman G, Curley S, Hohn D, Roh M. Improved survival after resection of colorectal liver metastases. Ann Surg Oncol 2:537, 1995CrossRefGoogle Scholar
  7. 7.
    Steele G, Bleday R, Mayer R, et al. A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: gastrointestinal Study Group Protocol 6584. J Clin Oncol 9:1105, 1991PubMedGoogle Scholar
  8. 8.
    Goslin R, Steele G, Zamcheck N, Mayer R, MacIntyre J. Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum. Dis Colon Rectum 25:749, 1982PubMedCrossRefGoogle Scholar
  9. 9.
    Heiken J, Weyman P, Lee J, et al. Detection of focal hepatic metastases: prospective evaluation with CT, delayed CT, DT during arterial portography, and MR imaging. Radiology 171:47, 1989PubMedGoogle Scholar
  10. 10.
    Nakamura S, Tsuzuki T. Surgical anatomy of the hepatic veins and the inferior vena cava. Surg Gynecol Obstet 152:43, 1981PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Charles R. Shumate

There are no affiliations available

Personalised recommendations